超級崩散劑市場規模、佔有率和成長分析：按產品類型、製劑/劑型、治療領域、最終用戶和地區分類－2026-2033年產業預測

2024 年全球超級崩散劑市場價值為 5.6785 億美元，預計從 2025 年的 6.1328 億美元成長到 2033 年的 11.3514 億美元，在預測期（2026-2033 年）內以 8.0% 的複合年成長率。

全球超級崩散劑市場是製藥業的重要組成部分，其核心在於能夠加速片劑與唾液接觸後崩壞的輔料聚合物，從而實現口服固體製劑中藥物的快速釋放。該領域的成長動力源於對速崩解錠能夠顯著提高包括兒童和老年人在內的各類患者群體的用藥依從性。儘管交聯羧甲基纖維素鈉和羥乙酸鈉澱粉等創新材料正在拓展製劑的可能性，但以患者為中心的給藥方式才是推動全球市場成長的主要動力，尤其是在新興經濟體。個人化醫療的快速發展要求製劑研發人員將先進的速超級崩散劑融入複雜的劑型中，而生產商也正在探索能夠實現快速溶解的可靠聚合物。此外，人工智慧在製劑研發中的自動化應用，透過簡化產品開發流程、提高品質一致性以及加快產品上市速度，為該領域創造了巨大的成長機會。

全球超級崩散劑市場成長要素

在口腔崩壞藥需求日益成長的推動下，製藥公司正超級崩散劑添加到藥片配方中。這有助於提高患者的用藥依從性和治療效果。這些超級崩散劑與唾液接觸後迅速崩壞，提高了給藥的便利性，尤其適用於老年患者和兒童患者。為了滿足這一需求，製造商正日益重視先進超級崩散劑技術的研究與開發，不僅透過創新產品推動市場成長，也拓展了其治療應用範圍。此外，這些藥物溶解度的提高符合生物等效性的監管標準，以便於其在學名藥和品牌藥的開發中得到應用。

全球超級崩散劑市場的限制因素

全球超級崩散劑市場面臨許多挑戰，其中之一便是輔料安全性和品質法律規範的複雜性，可能顯著延長產品核准時間。漫長的核准流程為尋求將新型超級崩散劑推向市場的製造商帶來了不確定性。由於需要進行全面的毒性評估、穩定性測試以及完善的合規性文件，研發成本和資源需求不斷增加。因此，企業可能會推遲對創新崩壞技術的投資，或選擇已獲得監管部門批准的現有成分。這一趨勢阻礙了市場成長，限制了製藥業對尖端解決方案的應用，同時核准時間的不確定性也使供應鏈規劃更加複雜。

全球超級崩散劑市場趨勢

全球超級崩散劑市場正經歷著向永續性的顯著轉變，製藥公司正致力於開發環境友善超級崩散劑替代品。這項轉變凸顯了可生物分解和植物來源聚合物的應用，這些聚合物不僅能最大限度地減少對環境的影響，還能滿足關鍵的性能標準。製劑研發人員正在調整與供應商的關係，將永續實踐融入輔料組合，從而優先考慮負責任的採購。隨著消費者環保意識的增強和對綠色標籤產品需求的不斷成長，企業正利用這些永續材料來實現差異化競爭、加強合規性並提升品牌信譽。總而言之，這一趨勢反映了整個製藥業對環保生產方式的更廣泛承諾。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 宏觀經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球超級崩散劑市場規模：依產品類型分類

• 交聯羧甲基纖維素鈉
• 交聯聚維酮（Polyplasdon）
• 澱粉羥乙酸鈉（SSG）
• 離子交換樹脂
• 改性纖維素
• 天然系超級崩散劑
• 其他

全球超級崩散劑市場規模：以劑型/劑型分類

• 片劑和膠囊
• 口溶錠（ODT）
• 口腔內溶解膜（MDF）
• 顆粒/丸劑

全球超級崩散劑市場規模：依治療領域分類

• 心血管系統
• 中樞神經系統（CNS）
• 消化器官系統
• 腫瘤學
• 其他

全球超級崩散劑市場規模：依最終用戶分類

• 製藥公司
• CDMO 和 CRO
• 營養補充品製造商

全球超級崩散劑市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Ashland Global Holdings Inc.
• Nippon Soda Co., Ltd.
• Dow Inc.（The Dow Chemical Company）
• JRS Pharma（J. Rettenmaier & Sohne）
• FMC Corporation（IFF Health）
• DFE Pharma
• Asahi Kasei Corporation
• LyondellBasell Industries NV
• Roquette Freres
• Colorcon, Inc.（Berry Global）
• Sigma-Aldrich（Merck KGaA）
• Carl Roth GmbH
• CMC Biopharmaceuticals A/S
• Avacta Group PLC
• Wyeth Pharmaceuticals（Pfizer）
• Hanmi Pharmaceutical Co., Ltd.
• Sinofi Ltd.
• Healtec Biosciences Ltd.
• MSD（Merck Sharp & Dohme）
• BASF SE

結論與建議

Global Superdisintegrants Market size was valued at USD 567.85 Million in 2024 and is poised to grow from USD 613.28 Million in 2025 to USD 1135.14 Million by 2033, growing at a CAGR of 8.0% during the forecast period (2026-2033).

The global superdisintegrants market is integral to the pharmaceutical industry, focusing on excipient polymers that enhance tablet disintegration upon contact with saliva, thereby facilitating rapid drug release in oral solid dosage forms. The sector is driven by the increasing demand for fast-disintegrating tablets, which significantly improve patient compliance among diverse demographics, including pediatric and geriatric populations. Innovations such as croscarmellose sodium and sodium starch glycolate have expanded formulation possibilities, while the emphasis on patient-centric delivery bolsters market growth globally, particularly in emerging economies. The surge in personalized medicine drives formulators to incorporate advanced superdisintegrants in intricate dosage forms, prompting manufacturers to explore reliable polymers capable of rapid dissolution. Additionally, AI-driven formulation automation streamlines product development, enhances consistency, and accelerates market entry, positioning the sector for significant growth opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Superdisintegrants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Superdisintegrants Market Segments Analysis

Global superdisintegrants market is segmented by product type, formulation / dosage form, therapeutic area, end user and region. Based on product type, the market is segmented into Croscarmellose Sodium, Crospovidone (Polyplasdone), Sodium Starch Glycolate (SSG), Ion Exchange Resins, Modified Cellulose, Natural Superdisintegrants and Others. Based on formulation / dosage form, the market is segmented into Tablets & Capsules, Orally Disintegrating Tablets (ODTs), Mouth-Dissolving Films (MDFs) and Granules & Pellets. Based on therapeutic area, the market is segmented into Cardiovascular, Central Nervous System (CNS), Gastrointestinal, Oncology and Other Therapeutic Areas. Based on end user, the market is segmented into Pharmaceutical Manufacturers, CDMOs & CROs and Nutraceutical Manufacturers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Superdisintegrants Market

The growing demand for orally disintegrating medications is prompting pharmaceutical companies to incorporate superdisintegrants into tablet formulations, thereby improving patient adherence and therapeutic outcomes. These superdisintegrants facilitate rapid disintegration when they come into contact with saliva, making dosage forms more convenient, particularly for elderly and pediatric patients. To meet this demand, manufacturers are increasingly focused on researching and developing advanced superdisintegrant technologies, which not only drive market growth through innovative products but also expand therapeutic applications. Furthermore, the enhanced dissolution characteristics offered by these agents align with regulatory standards for bioequivalence, promoting their adoption in both generic and branded drug development.

Restraints in the Global Superdisintegrants Market

The Global Superdisintegrants market faces challenges due to intricate regulatory frameworks surrounding excipient safety and quality, which can significantly extend product approval timelines. This extended process generates uncertainty for manufacturers aiming to bring new superdisintegrants to the market. The requirements for comprehensive toxicological assessments, stability studies, and thorough compliance documentation lead to increased development costs and resource demands. As a result, companies may delay investments in innovative disintegrant technologies or opt for established ingredients that already have regulatory approval. This trend stifles market growth and restricts the introduction of cutting-edge solutions in pharmaceutical offerings, while also complicating supply chain planning due to uncertain approval timelines.

Market Trends of the Global Superdisintegrants Market

The Global Superdisintegrants market is witnessing a notable trend towards sustainability, as pharmaceutical manufacturers focus on eco-friendly superdisintegrant alternatives. This shift emphasizes the use of biodegradable and plant-derived polymers, which not only minimize environmental impact but also uphold essential performance criteria. By integrating sustainable practices into their excipient portfolios, formulators are reshaping supplier relationships to prioritize responsible sourcing. With increasing consumer awareness and demand for green-label products, companies are leveraging these sustainable materials to enhance differentiation, reinforce regulatory compliance, and bolster brand credibility. Overall, this trend reflects a broader commitment to environmentally conscious manufacturing within the pharmaceutical industry.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Superdisintegrants Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Croscarmellose Sodium
• Crospovidone (Polyplasdone)
• Sodium Starch Glycolate (SSG)
• Ion Exchange Resins
• Modified Cellulose
• Natural Superdisintegrants
• Others

Global Superdisintegrants Market Size by Formulation / Dosage Form & CAGR (2026-2033)

• Market Overview
• Tablets & Capsules
• Orally Disintegrating Tablets (ODTs)
• Mouth-Dissolving Films (MDFs)
• Granules & Pellets

Global Superdisintegrants Market Size by Therapeutic Area & CAGR (2026-2033)

• Market Overview
• Cardiovascular
• Central Nervous System (CNS)
• Gastrointestinal
• Oncology
• Other Therapeutic Areas

Global Superdisintegrants Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Manufacturers
• CDMOs & CROs
• Nutraceutical Manufacturers

Global Superdisintegrants Market Size & CAGR (2026-2033)

• North America (Product Type, Formulation / Dosage Form, Therapeutic Area, End User)
  • US
  • Canada
• Europe (Product Type, Formulation / Dosage Form, Therapeutic Area, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Formulation / Dosage Form, Therapeutic Area, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Formulation / Dosage Form, Therapeutic Area, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Formulation / Dosage Form, Therapeutic Area, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Ashland Global Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nippon Soda Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dow Inc. (The Dow Chemical Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JRS Pharma (J. Rettenmaier & Sohne)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FMC Corporation (IFF Health)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DFE Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LyondellBasell Industries N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon, Inc. (Berry Global)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich (Merck KGaA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Roth GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CMC Biopharmaceuticals A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avacta Group PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wyeth Pharmaceuticals (Pfizer)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hanmi Pharmaceutical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinofi Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Healtec Biosciences Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD (Merck Sharp & Dohme)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations